Collplant Biotechnologies Ltd ADR (CLGN)

Apr 15, 2025, 8:00 AM EDT - 8 days ago

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Mar 26, 2025, 7:58 PM EDT - 4 weeks ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 8:00 AM EDT - 4 weeks ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

SSYS

Mar 19, 2025, 7:00 AM EDT - 5 weeks ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 24, 2025, 7:00 AM EST - 2 months ago

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 12, 2025, 6:00 AM EST - 2 months ago

CollPlant Biotechnologies Provides a Corporate Update

Nov 27, 2024, 11:36 AM EST - 5 months ago

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

Nov 27, 2024, 7:00 AM EST - 5 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Nov 12, 2024, 7:00 AM EST - 5 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 20, 2024, 6:59 PM EDT - 8 months ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 7:00 AM EDT - 8 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

Aug 19, 2024, 8:30 AM EDT - 8 months ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

SSYS

Aug 6, 2024, 7:00 AM EDT - 9 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Jul 29, 2024, 7:00 AM EDT - 9 months ago

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jun 6, 2024, 7:00 AM EDT - 11 months ago

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

May 29, 2024, 12:02 PM EDT - 11 months ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

May 29, 2024, 7:00 AM EDT - 11 months ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 16, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 4, 2024, 1:15 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 7:17 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 26, 2024, 8:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 15, 2024, 8:00 AM EST - 1 year ago

CollPlant Issues Letter to Shareholders

Jan 8, 2024, 7:18 AM EST - 1 year ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 2, 2024, 7:00 AM EST - 1 year ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023, 2:21 PM EST - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 7:00 AM EST - 1 year ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 9, 2023, 8:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 1, 2023, 7:05 AM EDT - 1 year ago

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Sep 21, 2023, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

Sep 5, 2023, 7:00 AM EDT - 1 year ago

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

Aug 24, 2023, 11:27 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2023 Earnings Call Transcript

Aug 24, 2023, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

Aug 9, 2023, 9:02 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 9, 2023, 8:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Jun 26, 2023, 7:00 AM EDT - 1 year ago

CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement

May 24, 2023, 12:49 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2023 Earnings Call Transcript

May 24, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update

May 2, 2023, 9:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Apr 4, 2023, 8:26 AM EDT - 2 years ago

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

SSYS

Mar 29, 2023, 12:28 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript

Mar 29, 2023, 7:00 AM EDT - 2 years ago

Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update

Mar 14, 2023, 7:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 12, 2023, 6:31 AM EST - 2 years ago

CollPlant: Expanding End-Market Opportunities

Jan 4, 2023, 7:00 AM EST - 2 years ago

CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives

Jan 3, 2023, 7:00 AM EST - 2 years ago

CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form

Dec 1, 2022, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results

Nov 15, 2022, 7:00 AM EST - 2 years ago

CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis

Nov 7, 2022, 7:00 AM EST - 2 years ago

CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90

Nov 3, 2022, 7:00 AM EDT - 2 years ago

CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17

Oct 3, 2022, 7:00 AM EDT - 2 years ago

CollPlant to present at the Dawson James Small Cap Growth Conference on October 12